Status:
COMPLETED
Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Pharyngitis
Eligibility:
All Genders
18-18 years
Phase:
PHASE3
Brief Summary
We are proposing a study in which we utilize and augment the sore throat pain model to assess the analgesic effectiveness of celecoxib compared to placebo in patients with painful pharyngitis under ra...
Eligibility Criteria
Inclusion
- The patient must have a diagnosis of pharyngitis with objective findings of tonsillo-pharyngitis.
- The patient is willing to take "nothing by mouth" including inhaled treatments except trial medication during the two hours while at the site and following trial drug administration (e.g. not smoking, food, drink, candy, lozenges, chewing gum). The patient will be allowed food and drink between hours 2 and 24, but no other oral or inhaled treatments such as smoking, lozenges, chewing gum. After the two hour assessment, the patients will be allowed food and drink within one half-hour following any hourly evaluations sore throat.
Exclusion
- The patient has used any analgesic/antipyretic within 1 dosing interval preceding administration of the first dose of trial medication.
- The patient anticipates using any inhaled therapy including beta-agonists (e.g., ventolin) during the 24 hour trial period and, if used, has only used inhaled therapy on an intermittent basis in the week prior to the screening visit.
Key Trial Info
Start Date :
December 4 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2007
Estimated Enrollment :
269 Patients enrolled
Trial Details
Trial ID
NCT00402987
Start Date
December 4 2006
End Date
November 15 2007
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Connecticut Student Health Services
Storrs, Connecticut, United States, 06269-2011